SalaryGuide
AboutPricingFor Employers

Marketing jobs

3 marketing jobs

Penumbra logo
1 day ago

Vascular Product Marketing Intern - Temporary role (Part-time)

Penumbra

Alameda, CA (On-site)Internship$20/hr – $31/hr
Penumbra logo
3 months ago

Sr. Therapy Development Specialist

Penumbra

Baltimore, MD (Remote)$110K/yr – $185K/yr
Penumbra logo
5 months ago

Vascular Product Marketing Intern - Temporary role

Penumbra

Alameda, CA (On-site)Temporary$20/hr – $31/hr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

3 jobs
Penumbra logo

Vascular Product Marketing Intern - Temporary role (Part-time)

Penumbra

Alameda, CA (On-site)

$20/hr - $31/hrIn-houseInternshipIntern/new grad2+ years exp.
1 day ago
Penumbra logo

Sr. Therapy Development Specialist

Penumbra

Baltimore, MD (Remote)

$110K/yr - $185K/yrIn-houseSenior level8+ years exp.
3 months ago
Penumbra logo

Vascular Product Marketing Intern - Temporary role

Penumbra

Alameda, CA (On-site)

$20/hr - $31/hrIn-houseTemporaryIntern/new grad2+ years exp.
5 months ago
Penumbra logo
Penumbra

Vascular Product Marketing Intern - Temporary role (Part-time)

Alameda, CA (On-site)

$20/hr – $31/hrIntern/New Grad2+ years expInternship

Posted 1 day ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

You will own administrative support for marketing literature and tools, coordinate website updates, and help drive clinical data initiatives and trade show activities.

  • Support development and production of marketing literature and sales tools.
  • Assist in updating digital properties and content.
  • Contribute to clinical data gathering and publications planning to reinforce value propositions.

Job Description

Responsibilities

  • Provide administrative support for the development and production of new marketing literature and sales support tools.
  • Assist the Marketing Team in updating Vascular website.
  • Attend trade shows and meetings to develop an understanding of the clinical use of Penumbra products.
  • Participate in clinical data gathering and review activities, identifying major studies, key end points, upcoming trials and data release dates (PEN and competitive products) to support publications and scientific presentations that underpin Penumbra’s messages and clinical value propositions in the medical community.
  • Conduct ShowPad Audit and provide recommendations to the Team on what needs to be updated, removed, added, or re-vamped.
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures.
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company.
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures.
  • Perform other work-related duties as assigned.

Requirements

  • High school diploma with 2+ years of college with coursework in biology, neuroscience, business, or a related discipline and 1+ year of business, administrative, or marketing experience, or an equivalent combination of education and experience.
  • Proficiency with Word, PowerPoint, Excel and other standard office tools required.

Preferred

  • Excellent oral, written, and interpersonal communication skills.
  • Some exposure to digital marketing.

Benefits

  • A generous benefits package for eligible employees that includes medical, dental, vision, life, AD&D, short and long-term disability insurance, 401(k) with employer match, paid parental leave, eleven paid company holidays per year, a minimum of fifteen days of accrued vacation per year, which increases with tenure, and paid sick time in compliance with applicable law(s).
Penumbra logo

Penumbra

Founded in 1976, Penumbra wields the emotional, physical, and spiritual power of Black cultural expression to advance racial healing through nurturing Black art, promoting social equity, and inspiring creative resiliency. Once home to playwright August Wilson and standing as Minnesota’s sole Black professional theatre company, Penumbra garners national acclaim with a remarkable portfolio of nearly 200 plays and over 30 premieres, serving 40,000 patrons and 5,000 students annually. Building upon this 47-year history, the newly evolved Penumbra Center for Racial Healing, situated in the heart of Saint Paul’s Rondo neighborhood, extends its legacy through fresh artistic endeavors, robust equity and inclusion training, and wellness services. To learn more about the Penumbra Center of Racial Healing, please visit penumbratheatre.org.Connect with us on Twitter @PenumbraTheatre and Instagram @PenumbraTheatre and like us on Facebook.

Founded in 1976
St Paul, Minnesota, USA
36 employees (13 in marketing)
penumbratheatre.org

Traffic Signals

Monthly Visitors
12.1K
Monthly Google Ads Budget
$17.4K
Traffic Source Mix
Search
29.5%
Direct
46.6%
Referral
5.9%
Social
16.5%
Paid
1.4%

Headcount Trend

Current headcount: ~36

Marketing Team

Marketing Team Size
10 (28% of company)
Median Tenure
8.7 years
Marketing Roles Posted (Last 30 Days)
1

Recent News

Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Nov 19, 2025 • PR Newswire
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
Nov 11, 2025 • Yahoo Finance
Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
Nov 11, 2025 • Zacks Investment Research
Do Options Traders Know Something About Penumbra Stock We Don't?
Nov 10, 2025 • Yahoo Finance
Penumbra, Inc. Just Recorded A 29% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 8, 2025 • Yahoo Finance
Penumbra price target raised to $355 from $350 at Canaccord
Nov 7, 2025 • Yahoo Finance
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Nov 5, 2025 • Yahoo Finance
More data supports Penumbra mechanical thrombectomy system
Nov 4, 2025 • MassDevice
What To Expect From Penumbra’s (PEN) Q3 Earnings
Nov 3, 2025 • Yahoo Finance
Is Penumbra’s Stock Still a Good Bet After a 7% Drop in the Past Month?
Oct 29, 2025 • Yahoo Finance
Penumbra's STORM-PE Sets Stage for PE Treatment Revolution
Oct 28, 2025 • Medical Device and Diagnostic industry
Why Penumbra (PEN) Shares Are Falling Today
Oct 28, 2025 • Yahoo Finance
Penumbra study backs mechanical thrombectomy for treating pulmonary embolism
Oct 27, 2025 • MassDevice
Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines?
Oct 26, 2025 • Investor's Business Daily
How Penumbra became a $1 billion leader in blood clot removal devices
Oct 23, 2025 • The Business Journals
Needham Upgrades Penumbra (PEN) to Buy Amid 2026 Growth Outlook
Oct 20, 2025 • Yahoo Finance
Risk Recap: How Penumbra Inc. stock responds to policy changes - Stop Loss & Weekly Watchlist for Hot Stocks
Oct 18, 2025 • nchmf.gov.vn
Penumbra (PEN): Evaluating Valuation After Needham Upgrade and 2026 Growth Catalysts
Oct 13, 2025 • Yahoo Finance
Theater review: Penumbra’s powerful ‘Marisol’ offers a captivating chaos
Oct 10, 2025 • Pioneer Press
Penumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
Oct 9, 2025 • BioSpace
Penumbra stock rating upgraded to Buy at Needham on expected 2026 growth
Oct 8, 2025 • Investing.com
Oct 26 Investor Event — Penumbra Hosts TCT Presentation; Earnings Release Nov 5
Oct 8, 2025 • Stock Titan
Penumbra’s SWOT analysis: thrombectomy leader’s stock poised for growth
Sep 22, 2025 • Investing.com
What Makes Penumbra (PEN) a Good Investment?
Sep 18, 2025 • Insider Monkey
Penumbra receives European CE mark for SwiftPAC neuroembolisation coils
Sep 16, 2025 • NeuroNews International
Needham maintains Hold rating on Penumbra stock ahead of PE trial results
Sep 8, 2025 • Investing.com
Penumbra Inc Stock (PEN) Opinions on Insider Sales and Analyst Ratings
Sep 5, 2025 • Quiver Quantitative
Evercore ISI initiates Penumbra stock with Outperform rating on growth outlook
Sep 2, 2025 • Investing.com
Penumbra Names Shruthi Narayan President
Sep 1, 2025 • Alameda Post
Why Is Penumbra (PEN) Up 5% Since Last Earnings Report?
Aug 28, 2025 • Yahoo Finance
Medical Device Leader Penumbra Elevates 20-Year Industry Veteran Shruthi Narayan to President Role
Aug 27, 2025 • Stock Titan
Penumbra, Inc. Names Shruthi Narayan as Company President
Aug 27, 2025 • PR Newswire
Shruthi Narayan appointed president of Penumbra
Aug 27, 2025 • NeuroNews International
Investing in Penumbra (NYSE:PEN) three years ago would have delivered you a 49% gain
Aug 22, 2025 • simplywall.st
Healthcare Tech Leader Penumbra Scheduled for Wells Fargo and Morgan Stanley September Conferences
Aug 20, 2025 • Stock Titan
Penumbra, Inc. to Present at Upcoming Investor Conferences – Company Announcement
Aug 20, 2025 • Financial Times
Penumbra, Inc. to Present at Upcoming Investor Conferences
Aug 20, 2025 • PR Newswire
Arani Bose sells Penumbra shares worth $3m
Aug 15, 2025 • Investing.com
Penumbra Inc director Wilder sells $89k in stock
Aug 13, 2025 • Investing.com
5 Insightful Analyst Questions From Penumbra’s Q2 Earnings Call
Aug 11, 2025 • Yahoo Finance
Penumbra PEN Q2 2025 Earnings Call Transcript
Aug 4, 2025 • The Motley Fool
Penumbra Second Quarter 2025 Earnings: Beats Expectations
Jul 31, 2025 • Yahoo Finance
Penumbra Inc (PEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Jul 30, 2025 • Yahoo Finance
Penumbra (PEN) Shares Skyrocket, What You Need To Know
Jul 30, 2025 • TradingView
Penumbra (PEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Jul 29, 2025 • Yahoo Finance
Penumbra shares surge as thrombectomy leader beats Q2 expectations
Jul 29, 2025 • Investing.com
Penumbra, Inc. Reports Strong Q2 2025 Results
Jul 29, 2025 • TipRanks
Penumbra, Inc. Reports Second Quarter 2025 Financial Results
Jul 29, 2025 • PR Newswire
Penumbra, Inc.'s (NYSE:PEN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jul 20, 2025 • simplywall.st
Mark Your Calendar: Penumbra Q2 2025 Earnings Call Coming July 29 After Market Close
Jul 1, 2025 • Stock Titan
Penumbra: AI Meets Aspiration - Why The Stock Is A Structural Winner
Jun 26, 2025 • Seeking Alpha
Penumbra may gain market share in peripheral embolisation coils with Ruby XL
Jun 20, 2025 • Medical Device Network
Inquis, Penumbra advance thrombectomy treatments
Jun 17, 2025 • BioWorld MedTech
Penumbra completes enrollment in pulmonary embolism trial
Jun 16, 2025 • MassDevice
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
Jun 16, 2025 • PR Newswire
Penumbra Completes Enrollment for STORM-PE Randomized Controlled Trial
Jun 16, 2025 • Diagnostic and Interventional Cardiology
Penumbra launches Ruby XL coil system for large vessel embolization
Jun 9, 2025 • MassDevice
Penumbra Introduces the Ruby® XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
Jun 5, 2025 • PR Newswire
Penumbra CEO Adam Elsesser sells $4.37 million in stock
May 30, 2025 • Investing.com
Managing Acute Limb Ischemia With Penumbra Lightning Bolt™ Technology
May 14, 2025 • HMP Global Learning Network
Why IBD Stock Of The Day Penumbra, Up 27% This Year, Is Making A Comeback
May 9, 2025 • Investor's Business Daily
Penumbra Theatre Sets the Stage for Black American Artistry and Healing
May 9, 2025 • Hyperallergic
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
Apr 29, 2025 • PR Newswire
Exclusive: Penumbra Management Team Set for Key Presentation at BofA Healthcare Conference
Apr 29, 2025 • Stock Titan
Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Apr 26, 2025 • Yahoo Finance
Penumbra Inc (PEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst International ...
Apr 24, 2025 • Yahoo Finance
Penumbra announces Red 72 Silver Label product featuring company’s latest engineering enhancements
Apr 24, 2025 • NeuroNews International
Penumbra Inc SEC 10-Q Report
Apr 23, 2025 • TradingView
Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars
Apr 23, 2025 • Yahoo Finance
Penumbra, Inc. Reports First Quarter 2025 Financial Results
Apr 23, 2025 • PR Newswire
Penumbra CEO Adam Elsesser sells $4.54 million in stock
Apr 18, 2025 • Investing.com
Investors more bullish on Penumbra (NYSE:PEN) this week as stock lifts 6.4%, despite earnings trending downwards over past five years
Apr 16, 2025 • simplywall.st
Penumbra (PEN) Earnings Expected to Grow: Should You Buy?
Apr 16, 2025 • Yahoo Finance
Cautious Outlook on Penumbra’s Thunderbolt Amid Trial Uncertainty and Market Delay
Apr 16, 2025 • TipRanks
Penumbra (PEN) Expected to Announce Quarterly Earnings on Wednesday
Apr 16, 2025 • Defense World
LPL Financial LLC Increases Stake in Penumbra, Inc. (NYSE:PEN)
Apr 15, 2025 • Defense World
Truist Financial Cuts Penumbra (NYSE:PEN) Price Target to $315.00
Apr 14, 2025 • Defense World
Reasons to Retain Penumbra Stock in Your Portfolio for Now
Apr 8, 2025 • Nasdaq
Seven New Data Sets Demonstrate Penumbra's Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
Apr 2, 2025 • PR Newswire
Penumbra Inc.: Will Its Market Penetration & Access Initiatives Help Capture The Thrombectomy Market?
Mar 3, 2025 • Smartkarma
Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail
Mar 1, 2025 • MSN
Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access
Feb 28, 2025 • NeuroNews International
Penumbra (NYSE:PEN) Downgraded to Hold Rating by StockNews.com
Feb 28, 2025 • Defense World
Blue Trust Inc. Sells 268 Shares of Penumbra, Inc. (NYSE:PEN)
Feb 26, 2025 • Defense World
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
Feb 24, 2025 • BioSpace
Penumbra Inc. Earnings Call Reveals Strong U.S. Growth
Feb 19, 2025 • TipRanks
Penumbra’s Impressive Surge: What’s Behind It?
Feb 19, 2025 • StocksToTrade
Penumbra Inc (PEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid International ...
Feb 18, 2025 • Yahoo Finance
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 18, 2025 • PR Newswire
Review: Penumbra’s ‘Paradise Blue’ tackles a haunted Miles Davis-like figure with exquisite power
Feb 14, 2025 • Star Tribune
Paradise Blue: A powerful Black experience at Penumbra Theatre
Feb 13, 2025 • Minnesota Spokesman-Recorder
Penumbra Theatre musical "Paradise Blue" aiming to stir up meaningful conversations
Feb 12, 2025 • CBS News
Penumbra launches Element vascular access system for VTE
Feb 3, 2025 • Venous News
Penumbra Launches Laser-Cut Hypotube Sheath Designed for Venous Thromboembolism
Jan 30, 2025 • Diagnostic and Interventional Cardiology
Reasons to Add Penumbra Stock to Your Portfolio Now
Jan 7, 2025 • Yahoo Finance
Penumbra stock rises following Stryker's Inari Medical acquisition
Jan 7, 2025 • Investing.com
Review: With return of grieving star, Penumbra’s ‘Black Nativity’ strikes a deeply personal note
Dec 10, 2024 • Star Tribune
Penumbra reveals positive data for algorithm-assisted thrombectomy tech
Nov 6, 2024 • Clinical Trials Arena
Penumbra Theatre founding company member Terry Bellamy dies at 70
Jan 23, 2023 • Twin Cities